MBX Biosciences Inc (NASDAQ: MBX) on Friday, soared 18.18% from the previous trading day, before settling in for the closing price of $6.27. Within the past 52 weeks, MBX’s price has moved between $4.81 and $27.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 53.23%. With a float of $15.98 million, this company’s outstanding shares have now reached $33.42 million.
The extent of productivity of a business whose workforce counts for 43 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
MBX Biosciences Inc (MBX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of MBX Biosciences Inc is 52.13%, while institutional ownership is 50.08%. The most recent insider transaction that took place on Apr 08 ’25, was worth 45,312. In this transaction Director of this company bought 7,693 shares at a rate of $5.89, taking the stock ownership to the 24,329 shares. Before that another transaction happened on Feb 18 ’25, when Company’s Director bought 143,170 for $10.84, making the entire transaction worth $1,551,963. This insider now owns 3,255,000 shares in total.
MBX Biosciences Inc (MBX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.71 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.23% per share during the next fiscal year.
MBX Biosciences Inc (NASDAQ: MBX) Trading Performance Indicators
MBX Biosciences Inc (MBX) is currently performing well based on its current performance indicators. A quick ratio of 24.19 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.85, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.74 in one year’s time.
Technical Analysis of MBX Biosciences Inc (MBX)
The latest stats from [MBX Biosciences Inc, MBX] show that its last 5-days average volume of 0.59 million was superior to 0.3 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 60.52%. Additionally, its Average True Range was 0.96.
During the past 100 days, MBX Biosciences Inc’s (MBX) raw stochastic average was set at 13.43%, which indicates a significant decrease from 76.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 107.33% in the past 14 days, which was higher than the 104.31% volatility it showed in the past 100 days.
Now, the first resistance to watch is $8.04. This is followed by the second major resistance level at $8.68. The third major resistance level sits at $9.53. If the price goes on to break the first support level at $6.56, it is likely to go to the next support level at $5.71. The third support level lies at $5.07 if the price breaches the second support level.
MBX Biosciences Inc (NASDAQ: MBX) Key Stats
Market capitalization of the company is 247.64 million based on 33,424K outstanding shares. Right now, sales total 0 K and income totals -61,922 K. The company made 0 K in profit during its latest quarter, and -15,586 K in sales during its previous quarter.
